Cipla to invest in South Africa’s first biosimilars production facility
Indian-based pharmaceutical and biotechnology company Cipla will invest more than R1.3bn ($19.34m) in the first advanced biotech manufacturing facility in South Africa for the production of biosimilars.
Indian-based pharmaceutical and biotechnology company Cipla will invest more than R1.3bn ($19.34m) in the first advanced biotech manufacturing facility in South Africa for the production of biosimilars.
The investment will be carried out by South African subsidiary Cipla BioTec…………………cont
read at
Cipla Managing director and global CEO Subhanu Saxena
Dr Y.K. Hamied,
Department of Trade and Industries Special Economic Zone of Dube Tradeport, DURBAN, SOUTHAFRICA
///Cipla, South Africa, biosimilars, production facility, Dube Tradeport, Cipla BioTec Pvt Ltd, Durban, SOUTHAFRICA
